Drug comparisons
Canagliflozin vs Insulin Glulisine Human
Canagliflozin (Invokana) vs Insulin Glulisine (Apidra): Oral SGLT2 inhibitor vs rapid-acting insulin. Compare uses in T2D vs T1D, mechanisms, and administration.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when deciding between continuing oral SGLT2 inhibitor therapy or initiating rapid-acting insulin in progressing type 2 diabetes or when managing type 1 diabetes.
Bottom line
Neither is better overall because they address different diabetes types and treatment stages via unrelated mechanisms.
All medication comparisons